查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
慢性肾臟病(CKD)营养补充品的全球市场(各营养类型):产业分析，市场规模，占有率，成长，趋势，预测(2021年～2031年)
市场调查报告书
商品编码
1140661

慢性肾臟病(CKD)营养补充品的全球市场(各营养类型):产业分析，市场规模，占有率，成长，趋势，预测(2021年～2031年)

Chronic Kidney Disease [CKD] Nutritional Supplement Market (Nutrition Type: Amino Acid Supplements, Vitamin & Mineral Supplements, Probiotics, Prebiotics/Fibers, & Others) - Global Industry Analysis, Size, Share, Growth, Trends, & Forecast, 2021-2031
出版日期: | 出版商: Transparency Market Research | 英文 217 Pages | 商品交期: 2-10个工作天内

价格

本报告提供全球慢性肾臟病(CKD)营养补充品市场相关调查分析，提供市场概要，市场分析，竞争情形等系统性资讯。

目录

第1章 序文

第2章 前提与调查手法

第3章 摘要整理:全球慢性肾臟病(CKD)营养补充品市场

第4章 市场概要

  • 概要
  • 市场动态
    • 促进因素
    • 阻碍因素
    • 机会
  • 全球慢性肾臟病(CKD)营养补充品市场分析与预测(2017年～2031年)

第5章 主要洞察

  • 平均价格:各营养类型
  • 波特的五力分析
  • COVID-19影响分析
  • 全球慢性肾臟病的盛行率

第6章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各营养类型

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各营养类型
    • 氨基酸补充品
    • 维生素和矿物质补充品
    • 益生菌
    • 益生元/纤维
    • 其他
  • 市场魅力分析:各营养类型

第7章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各剂型

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各剂型
    • 胶囊
    • 液状
    • 粉末
    • 其他
  • 市场魅力分析:各剂型

第8章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各FSMP投药法

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各FSMP投药法
    • 口服营养(ON)
    • 经肠营养(EN)
  • 市场魅力分析:各FSMP投药法

第9章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各慢性肾臟病阶段

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各慢性肾臟病阶段
    • 透析前阶段1～2
    • 透析前阶段3～5
    • 透析
    • 末期肾臟病
  • 市场魅力分析:各慢性肾臟病阶段

第10章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各流通管道

  • 简介和定义
  • 主要调查结果/开发
  • 市场金额预测(2017年～2031年):各流通管道
    • 医院药局
    • 零售药局
    • 网路商店
  • 市场魅力分析:各流通管道

第11章 全球慢性肾臟病(CKD)营养补充品市场分析与预测:各地区

  • 主要调查结果
  • 市场金额预测:各地区
    • 北美
    • 欧洲
    • 亚太地区
    • 南美
    • 中东·非洲
  • 市场魅力分析:各地区

第12章 北美的慢性肾臟病(CKD)营养补充品市场分析与预测

第13章 欧洲的慢性肾臟病(CKD)营养补充品市场分析与预测

第14章 亚太地区的慢性肾臟病(CKD)营养补充品市场分析与预测

第15章 南美的慢性肾臟病(CKD)营养补充品市场分析与预测

第16章 中东·非洲的慢性肾臟病(CKD)营养补充品市场分析与预测

第17章 竞争情形

  • 市场参与企业:竞争矩阵(各水准及各企业规模)
  • 市场占有率分析/排行榜(2021年):各企业
  • 企业简介
    • Abbott Laboratories
    • Ajanta Pharma Limited
    • Fresenius Kabi AG
    • Hexagon Nutrition Limited
    • Mankind Pharma Ltd.
    • Nestle SA
    • Nutricia Limited(Danone SA)
    • PRINE Health MSO, LLC
    • RPG Life Sciences Limited
Product Code: TMRGL84899

Scope of Report

The report provides revenue of the global chronic kidney disease nutritional supplement market for the period 2017-2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global chronic kidney disease nutritional supplement market from 2022 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the chronic kidney disease nutritional supplement market.

The report delves into the competitive landscape of the global chronic kidney disease nutritional supplement market. Key players operating in the global chronic kidney disease nutritional supplement market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global chronic kidney disease nutritional supplement market profiled in this report.

Table of Contents

1. Preface

  • 1.1. Market Definition and Scope
  • 1.2. Market Segmentation
  • 1.3. Key Research Objectives
  • 1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Chronic Kidney Disease Nutritional Supplement Market

4. Market Overview

  • 4.1. Overview
  • 4.2. Market Dynamics
    • 4.2.1. Drivers
    • 4.2.2. Restraints
    • 4.2.3. Opportunities
  • 4.3. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, 2017-2031

5. Key Insights

  • 5.1. Average Pricing Per Nutrition Type
  • 5.2. Porter's Five Force Analysis
  • 5.3. COVID-19 Impact Analysis
  • 5.4. Prevalence of Chronic Kidney Diseases Globally

6. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type

  • 6.1. Introduction & Definition
  • 6.2. Key Findings/Developments
  • 6.3. Market Value Forecast, by Nutrition Type, 2017-2031
    • 6.3.1. Amino Acid Supplements
      • 6.3.1.1. Alpha-Ketoanalogue Supplements
      • 6.3.1.2. Alpha Lipoic Acid Supplements
      • 6.3.1.3. Others
    • 6.3.2. Vitamin & Mineral Supplements
    • 6.3.3. Probiotics
    • 6.3.4. Prebiotics/Fibers
    • 6.3.5. Others
  • 6.4. Market Attractiveness Analysis, by Nutrition Type

7. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form

  • 7.1. Introduction & Definition
  • 7.2. Key Findings/Developments
  • 7.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 7.3.1. Capsule Form
    • 7.3.2. Liquid Form
    • 7.3.3. Powder Form
    • 7.3.4. Others
  • 7.4. Market Attractiveness Analysis, by Dosage Form

8. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration

  • 8.1. Introduction & Definition
  • 8.2. Key Findings/Developments
  • 8.3. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 8.3.1. Oral Nutrition (ON)
    • 8.3.2. Enteral Nutrition (EN)
  • 8.4. Market Attractiveness Analysis, by FSMP Mode of Administration

9. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage

  • 9.1. Introduction & Definition
  • 9.2. Key Findings/Developments
  • 9.3. Market Value Forecast, by CKD Stage, 2017-2031
    • 9.3.1. Pre-dialysis Stage 1-2
    • 9.3.2. Pre-dialysis Stage 3-5
    • 9.3.3. Dialysis
    • 9.3.4. End-stage Renal Disease
  • 9.4. Market Attractiveness Analysis, by CKD Stage

10. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel

  • 10.1. Introduction & Definition
  • 10.2. Key Findings/Developments
  • 10.3. Market Value Forecast, by Distribution Channel, 2017-2031
    • 10.3.1. Hospital Pharmacies
    • 10.3.2. Retail Pharmacies
    • 10.3.3. Online Stores
  • 10.4. Market Attractiveness Analysis, by Distribution Channel

11. Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Region

  • 11.1. Key Findings
  • 11.2. Market Value Forecast, by Region
    • 11.2.1. North America
    • 11.2.2. Europe
    • 11.2.3. Asia Pacific
    • 11.2.4. Latin America
    • 11.2.5. Middle East & Africa
  • 11.3. Market Attractiveness Analysis, by Region

12. North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast

  • 12.1. Introduction
    • 12.1.1. Key Findings
  • 12.2. Market Value Forecast, by Nutrition Type, 2017-2031
    • 12.2.1. Amino Acid Supplements
      • 12.2.1.1. Alpha-Ketoanalogue Supplements
      • 12.2.1.2. Alpha Lipoic Acid Supplements
      • 12.2.1.3. Others
    • 12.2.2. Vitamin & Mineral Supplements
    • 12.2.3. Probiotics
    • 12.2.4. Prebiotics/Fibers
    • 12.2.5. Others
  • 12.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 12.3.1. Capsule Form
    • 12.3.2. Liquid Form
    • 12.3.3. Powder Form
    • 12.3.4. Others
  • 12.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 12.4.1. Oral Nutrition (ON)
    • 12.4.2. Enteral Nutrition (EN)
  • 12.5. Market Value Forecast, by CKD Stage, 2017-2031
    • 12.5.1. Pre-dialysis Stage 1-2
    • 12.5.2. Pre-dialysis Stage 3-5
    • 12.5.3. Dialysis
    • 12.5.4. End-stage Renal Disease
  • 12.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 12.6.1. Hospital Pharmacies
    • 12.6.2. Retail Pharmacies
    • 12.6.3. Online Stores
  • 12.7. Market Value Forecast, by Country, 2017-2031
    • 12.7.1. U.S.
    • 12.7.2. Canada
  • 12.8. Market Attractiveness Analysis
    • 12.8.1. By Nutrition Type
    • 12.8.2. By Dosage Form
    • 12.8.3. By FSMP Mode of Administration
    • 12.8.4. By CKD stage
    • 12.8.5. By Distribution Channel
    • 12.8.6. By Country

13. Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast

  • 13.1. Introduction
    • 13.1.1. Key Findings
  • 13.2. Market Value Forecast, by Nutrition Type, 2017-2031
    • 13.2.1. Amino Acid Supplements
      • 13.2.1.1. Alpha-Ketoanalogue Supplements
      • 13.2.1.2. Alpha Lipoic Acid Supplements
      • 13.2.1.3. Others
    • 13.2.2. Vitamin & Mineral Supplements
    • 13.2.3. Probiotics
    • 13.2.4. Prebiotics/Fibers
    • 13.2.5. Others
  • 13.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 13.3.1. Capsule Form
    • 13.3.2. Liquid Form
    • 13.3.3. Powder Form
    • 13.3.4. Others
  • 13.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 13.4.1. Oral Nutrition (ON)
    • 13.4.2. Enteral Nutrition (EN)
  • 13.5. Market Value Forecast, by CKD Stage, 2017-2031
    • 13.5.1. Pre-dialysis Stage 1-2
    • 13.5.2. Pre-dialysis Stage 3-5
    • 13.5.3. Dialysis
    • 13.5.4. End-stage Renal Disease
  • 13.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 13.6.1. Hospital Pharmacies
    • 13.6.2. Retail Pharmacies
    • 13.6.3. Online Stores
  • 13.7. Market Value Forecast By Country/Sub-region, 2017-2031
    • 13.7.1. Germany
    • 13.7.2. U.K.
    • 13.7.3. France
    • 13.7.4. Spain
    • 13.7.5. Italy
    • 13.7.6. Rest of Europe
  • 13.8. Market Attractiveness Analysis
    • 13.8.1. By Nutrition Type
    • 13.8.2. By Dosage Form
    • 13.8.3. By FSMP Mode of Administration
    • 13.8.4. By CKD stage
    • 13.8.5. By Distribution Channel
    • 13.8.6. By Country/Sub-region

14. Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast

  • 14.1. Introduction
    • 14.1.1. Key Findings
  • 14.2. Market Value Forecast, by Nutrition Type, 2017-2031
    • 14.2.1. Amino Acid Supplements
      • 14.2.1.1. Alpha-Ketoanalogue Supplements
      • 14.2.1.2. Alpha Lipoic Acid Supplements
      • 14.2.1.3. Others
    • 14.2.2. Vitamin & Mineral Supplements
    • 14.2.3. Probiotics
    • 14.2.4. Prebiotics/Fibers
    • 14.2.5. Others
  • 14.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 14.3.1. Capsule Form
    • 14.3.2. Liquid Form
    • 14.3.3. Powder Form
    • 14.3.4. Others
  • 14.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 14.4.1. Oral Nutrition (ON)
    • 14.4.2. Enteral Nutrition (EN)
  • 14.5. Market Value Forecast, by CKD Stage, 2017-2031
    • 14.5.1. Pre-dialysis Stage 1-2
    • 14.5.2. Pre-dialysis Stage 3-5
    • 14.5.3. Dialysis
    • 14.5.4. End-stage Renal Disease
  • 14.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 14.6.1. Hospital Pharmacies
    • 14.6.2. Retail Pharmacies
    • 14.6.3. Online Stores
  • 14.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 14.7.1. China
    • 14.7.2. Japan
    • 14.7.3. India
    • 14.7.4. Taiwan
    • 14.7.5. Australia & New Zealand
    • 14.7.6. Rest of Asia Pacific
  • 14.8. Market Attractiveness Analysis
    • 14.8.1. By Nutrition Type
    • 14.8.2. By Dosage Form
    • 14.8.3. By FSMP Mode of Administration
    • 14.8.4. By CKD stage
    • 14.8.5. By Distribution Channel
    • 14.8.6. By Country/Sub-region

15. Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast

  • 15.1. Introduction
    • 15.1.1. Key Findings
  • 15.2. Market Value Forecast, by Nutrition Type, 2017-2031
    • 15.2.1. Amino Acid Supplements
      • 15.2.1.1. Alpha-Ketoanalogue Supplements
      • 15.2.1.2. Alpha Lipoic Acid Supplements
      • 15.2.1.3. Others
    • 15.2.2. Vitamin & Mineral Supplements
    • 15.2.3. Probiotics
    • 15.2.4. Prebiotics/Fibers
    • 15.2.5. Others
  • 15.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 15.3.1. Capsule Form
    • 15.3.2. Liquid Form
    • 15.3.3. Powder Form
    • 15.3.4. Others
  • 15.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 15.4.1. Oral Nutrition (ON)
    • 15.4.2. Enteral Nutrition (EN)
  • 15.5. Market Value Forecast, by CKD Stage, 2017-2031
    • 15.5.1. Pre-dialysis Stage 1-2
    • 15.5.2. Pre-dialysis Stage 3-5
    • 15.5.3. Dialysis
    • 15.5.4. End-stage Renal Disease
  • 15.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 15.6.1. Hospital Pharmacies
    • 15.6.2. Retail Pharmacies
    • 15.6.3. Online Stores
  • 15.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 15.7.1. Brazil
    • 15.7.2. Mexico
    • 15.7.3. Rest of Latin America
  • 15.8. Market Attractiveness Analysis
    • 15.8.1. By Nutrition Type
    • 15.8.2. By Dosage Form
    • 15.8.3. By FSMP Mode of Administration
    • 15.8.4. By CKD stage
    • 15.8.5. By Distribution Channel
    • 15.8.6. By Country/Sub-region

16. Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast

  • 16.1. Introduction
    • 16.1.1. Key Findings
  • 16.2. Market Value Forecast, by Nutrition Type, 2017-2031
    • 16.2.1. Amino Acid Supplements
      • 16.2.1.1. Alpha-Ketoanalogue Supplements
      • 16.2.1.2. Alpha Lipoic Acid Supplements
      • 16.2.1.3. Others
    • 16.2.2. Vitamin & Mineral Supplements
    • 16.2.3. Probiotics
    • 16.2.4. Prebiotics/Fibers
    • 16.2.5. Others
  • 16.3. Market Value Forecast, by Dosage Form, 2017-2031
    • 16.3.1. Capsule Form
    • 16.3.2. Liquid Form
    • 16.3.3. Powder Form
    • 16.3.4. Others
  • 16.4. Market Value Forecast, by FSMP Mode of Administration, 2017-2031
    • 16.4.1. Oral Nutrition (ON)
    • 16.4.2. Enteral Nutrition (EN)
  • 16.5. Market Value Forecast, by CKD Stage, 2017-2031
    • 16.5.1. Pre-dialysis Stage 1-2
    • 16.5.2. Pre-dialysis Stage 3-5
    • 16.5.3. Dialysis
    • 16.5.4. End-stage Renal Disease
  • 16.6. Market Value Forecast, by Distribution Channel, 2017-2031
    • 16.6.1. Hospital Pharmacies
    • 16.6.2. Retail Pharmacies
    • 16.6.3. Online Stores
  • 16.7. Market Value Forecast, by Country/Sub-region, 2017-2031
    • 16.7.1. GCC Countries
    • 16.7.2. South Africa
    • 16.7.3. Rest of Middle East & Africa
  • 16.8. Market Attractiveness Analysis
    • 16.8.1. By Nutrition Type
    • 16.8.2. By Dosage Form
    • 16.8.3. By FSMP Mode of Administration
    • 16.8.4. By CKD stage
    • 16.8.5. By Distribution Channel
    • 16.8.6. By Country/Sub-region

17. Competition Landscape

  • 17.1. Market Player - Competition Matrix (by tier and size of companies)
  • 17.2. Market Share Analysis/Ranking, by Company, 2021
  • 17.3. Company Profiles
    • 17.3.1. Abbott Laboratories
      • 17.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.1.2. Product Portfolio
      • 17.3.1.3. Financial Overview
      • 17.3.1.4. Strategic Overview
      • 17.3.1.5. SWOT Analysis
    • 17.3.2. Ajanta Pharma Limited
      • 17.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.2.2. Product Portfolio
      • 17.3.2.3. Financial Overview
      • 17.3.2.4. Strategic Overview
      • 17.3.2.5. SWOT Analysis
    • 17.3.3. Fresenius Kabi AG
      • 17.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.3.2. Product Portfolio
      • 17.3.3.3. Financial Overview
      • 17.3.3.4. Strategic Overview
      • 17.3.3.5. SWOT Analysis
    • 17.3.4. Hexagon Nutrition Limited
      • 17.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.4.2. Product Portfolio
      • 17.3.4.3. Financial Overview
      • 17.3.4.4. SWOT Analysis
    • 17.3.5. Mankind Pharma Ltd.
      • 17.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.5.2. Product Portfolio
      • 17.3.5.3. Strategic Overview
      • 17.3.5.4. SWOT Analysis
    • 17.3.6. Nestle S.A.
      • 17.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.6.2. Product Portfolio
      • 17.3.6.3. Financial Overview
      • 17.3.6.4. Strategic Overview
      • 17.3.6.5. SWOT Analysis
    • 17.3.7. Nutricia Limited (Danone S.A.)
      • 17.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.7.2. Product Portfolio
      • 17.3.7.3. Financial Overview
      • 17.3.7.4. Strategic Overview
      • 17.3.7.5. SWOT Analysis
    • 17.3.8. PRINE Health MSO, LLC
      • 17.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.8.2. Product Portfolio
      • 17.3.8.3. SWOT Analysis
    • 17.3.9. RPG Life Sciences Limited
      • 17.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
      • 17.3.9.2. Product Portfolio
      • 17.3.9.3. Financial Overview
      • 17.3.9.4. Strategic Overview
      • 17.3.9.5. SWOT Analysis

List of Tables

  • Table 01: Average Pricing Per Nutrition Type
  • Table 02: Average Pricing Per Nutrition Type
  • Table 03: Prevalence of Chronic Kidney Diseases Globally
  • Table 04: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 05: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 06: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
  • Table 07: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 08: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 09: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 10: Global Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Region, 2017-2031
  • Table 11: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 12: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 13: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 14: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 15: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 16: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 17: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country, 2017-2031
  • Table 18: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 19: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 20: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 21: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 22: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 23: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 24: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 25: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 26: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 27: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form, 2017-2031
  • Table 28: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 29: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 30: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 31: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 32: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 33: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 34: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
  • Table 35: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 36: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 37: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 38: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031
  • Table 39: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Nutrition Type, 2017-2031
  • Table 40: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Amino Acid Supplements, 2017-2031
  • Table 41: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Dosage Form , 2017-2031
  • Table 42: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by FSMP Mode of Administration, 2017-2031
  • Table 43: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by CKD Stage, 2017-2031
  • Table 44: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Distribution Channel, 2017-2031
  • Table 45: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017-2031

List of Figures

  • Figure 01: Global Chronic Kidney Disease Nutritional Supplement (CKD) Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 02: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 03: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 04: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Amino Acid Supplements, 2017-2031
  • Figure 05: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Vitamin & Mineral Supplements, 2017-2031
  • Figure 06: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Probiotics, 2017-2031
  • Figure 07: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Prebiotics/Fibers, 2017-2031
  • Figure 08: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Others, 2017-2031
  • Figure 09: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form 2021 and 2031
  • Figure 10: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 11: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Capsule Form, 2017-2031
  • Figure 12: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Liquid Form, 2017-2031
  • Figure 13: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Powder Form, 2017-2031
  • Figure 14: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Others, 2017-2031
  • Figure 15: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 16: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 17: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Oral Nutrition, 2017-2031
  • Figure 18: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Enteral Nutrition, 2017-2031
  • Figure 19: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 20: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 21: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Pre-dialysis Stage 1-2, 2017-2031
  • Figure 22: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Pre-dialysis Stage 3-5, 2017-2031
  • Figure 23: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Dialysis, 2017-2031
  • Figure 24: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by End-stage Renal Disease, 2017-2031
  • Figure 25: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 26: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 27: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Hospital Pharmacies, 2017-2031
  • Figure 28: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Retail Pharmacies, 2017-2031
  • Figure 29: Global Chronic Kidney Disease Nutritional Supplement Market (US$ Mn), by Online Stores, 2017-2031
  • Figure 30: Global Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Region, 2021 and 2031
  • Figure 31: Global Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Region, 2022-2031
  • Figure 32: North America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 33: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 34: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 35: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
  • Figure 36: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 37: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 38: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 39: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 40: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 41: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 42: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 43: North America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country, 2021 and 2031
  • Figure 44: North America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country, 2022-2031
  • Figure 45: Europe Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 46: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 47: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 48: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form. 2021 and 2031
  • Figure 49: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 50: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 51: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 52: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 53: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 54: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 55: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 56: Europe Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 57: Europe Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 58: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 59: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 60: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 61: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form 2021 and 2031
  • Figure 62: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 63: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 64: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 65: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 66: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 67: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 68: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 69: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 70: Asia Pacific Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 71: Latin America Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 72: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 73: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 74: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
  • Figure 75: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 76: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 77: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 78: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 79: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 80: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 81: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 82: Latin America Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 83: Latin America Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 84: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Value (US$ Mn) Forecast, 2017-2031
  • Figure 85: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Nutrition Type, 2021 and 2031
  • Figure 86: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Nutrition Type, 2022-2031
  • Figure 87: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Dosage Form, 2021 and 2031
  • Figure 88: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Dosage Form, 2022-2031
  • Figure 89: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by FSMP Mode of Administration, 2021 and 2031
  • Figure 90: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by FSMP Mode of Administration, 2022-2031
  • Figure 91: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by CKD Stage, 2021 and 2031
  • Figure 92: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by CKD Stage, 2022-2031
  • Figure 93: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Distribution Channel, 2021 and 2031
  • Figure 94: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Distribution Channel, 2022-2031
  • Figure 95: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Analysis and Forecast, by Country/Sub-region, 2021 and 2031
  • Figure 96: Middle East & Africa Chronic Kidney Disease Nutritional Supplement Market Attractiveness Analysis, by Country/Sub-region, 2022-2031
  • Figure 97: Global Chronic Kidney Disease Nutritional Supplement Market Share Analysis/Ranking, by Company, 2021